Published in Am J Pathol on October 01, 2005
Regulatory interactions between muscle and the immune system during muscle regeneration. Am J Physiol Regul Integr Comp Physiol (2010) 3.44
The dual roles of neutrophils and macrophages in inflammation: a critical balance between tissue damage and repair. J Athl Train (2007) 1.50
Aging-associated exacerbation in fatty degeneration and infiltration after rotator cuff tear. J Shoulder Elbow Surg (2013) 1.35
Local NSAID infusion inhibits satellite cell proliferation in human skeletal muscle after eccentric exercise. J Appl Physiol (1985) (2009) 1.11
Follistatin improves skeletal muscle healing after injury and disease through an interaction with muscle regeneration, angiogenesis, and fibrosis. Am J Pathol (2011) 1.07
Human inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment. Am J Physiol Regul Integr Comp Physiol (2013) 1.05
COX-2 inhibitor reduces skeletal muscle hypertrophy in mice. Am J Physiol Regul Integr Comp Physiol (2009) 1.05
IFN-γ promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferation. J Immunol (2011) 1.04
Inhibition of 5-LOX, COX-1, and COX-2 increases tendon healing and reduces muscle fibrosis and lipid accumulation after rotator cuff repair. Am J Sports Med (2014) 1.02
The effect of muscle loading on skeletal muscle regenerative potential: an update of current research findings relating to aging and neuromuscular pathology. Am J Phys Med Rehabil (2009) 0.98
Inflammation during skeletal muscle regeneration and tissue remodeling: application to exercise-induced muscle damage management. Immunol Cell Biol (2015) 0.95
Stem cells for the treatment of skeletal muscle injury. Clin Sports Med (2009) 0.94
Effect of a cyclooxygenase-2 inhibitor on postexercise muscle protein synthesis in humans. Am J Physiol Endocrinol Metab (2009) 0.92
Macrophage activation and skeletal muscle healing following traumatic injury. J Pathol (2014) 0.91
Biological approaches to improve skeletal muscle healing after injury and disease. Birth Defects Res C Embryo Today (2012) 0.91
The role of platelet-rich plasma in inducing musculoskeletal tissue healing. HSS J (2012) 0.90
Effects of prostaglandins and COX-inhibiting drugs on skeletal muscle adaptations to exercise. J Appl Physiol (1985) (2013) 0.87
Inhibition of prostaglandin D synthase suppresses muscular necrosis. Am J Pathol (2009) 0.86
The potential of stem cells in the treatment of skeletal muscle injury and disease. Stem Cells Int (2011) 0.85
Protein kinase Cε-calcineurin cosignaling downstream of toll-like receptor 4 downregulates fibrosis and induces wound healing gene expression in cardiac myofibroblasts. Mol Cell Biol (2013) 0.82
T lymphocytes are not required for the development of fatty degeneration after rotator cuff tear. Bone Joint Res (2014) 0.80
The heat shock protein response following eccentric exercise in human skeletal muscle is unaffected by local NSAID infusion. Eur J Appl Physiol (2013) 0.79
Cyclooxygenase-2 inhibitors modulate skin aging in a catalytic activity-independent manner. Exp Mol Med (2012) 0.78
The Development of Macrophage-Mediated Cell Therapy to Improve Skeletal Muscle Function after Injury. PLoS One (2015) 0.78
Hamstring muscle strain injuries: what can we learn from history? Br J Sports Med (2012) 0.78
Transforming Growth Factor Beta (TGF-β) Is a Muscle Biomarker of Disease Progression in ALS and Correlates with Smad Expression. PLoS One (2015) 0.77
Inhibition of p38 mitogen-activated protein kinase signaling reduces fibrosis and lipid accumulation after rotator cuff repair. J Shoulder Elbow Surg (2016) 0.77
Inhibition of COX1/2 alters the host response and reduces ECM scaffold mediated constructive tissue remodeling in a rodent model of skeletal muscle injury. Acta Biomater (2015) 0.76
Ischaemia-reperfusion modulates inflammation and fibrosis of skeletal muscle after contusion injury. Int J Exp Pathol (2010) 0.75
Arachidonic Acid Metabolite 19(S)-HETE Induces Vasorelaxation and Platelet Inhibition by Activating Prostacyclin (IP) Receptor. PLoS One (2016) 0.75
Characterization of a compartment syndrome-like injury model. Muscle Nerve (2015) 0.75
Regeneration of Skeletal Muscle Following Eccentric Injury. J Sport Rehabil (2016) 0.75
Resistance exercise and naproxen sodium: effects on a stable PGF2α metabolite and morphological adaptations of the upper body appendicular skeleton. Inflammopharmacology (2015) 0.75
Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature (1997) 14.82
F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol (1981) 12.96
Pax7 is required for the specification of myogenic satellite cells. Cell (2000) 9.88
The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology (1985) 7.77
Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol (1994) 7.36
Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science (1989) 5.61
Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J Cell Biol (2000) 5.04
Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev Biol (1997) 4.48
Cross-reaction of a rat-anti-mouse phagocyte-specific monoclonal antibody (anti-Mac-1) with human monocytes and natural killer cells. J Immunol (1981) 2.94
Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates. Nat Med (2003) 2.91
A new look at the origin, function, and "stem-cell" status of muscle satellite cells. Dev Biol (2000) 2.85
Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol (2004) 2.78
Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol (2000) 2.75
Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases. Proc Natl Acad Sci U S A (2003) 2.66
Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol (1998) 2.57
Cell heterogeneity upon myogenic differentiation: down-regulation of MyoD and Myf-5 generates 'reserve cells'. J Cell Sci (1998) 2.43
Muscle injuries and repair: current trends in research. J Bone Joint Surg Am (2002) 2.31
Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J Cell Biol (2003) 2.19
Anti-inflammatory medication after muscle injury. A treatment resulting in short-term improvement but subsequent loss of muscle function. J Bone Joint Surg Am (1995) 1.92
Myosin heavy chain isoforms in postnatal muscle development of mice. Biol Cell (2003) 1.78
Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol (2002) 1.74
Factors involved in the regulation of type I collagen gene expression: implication in fibrosis. Exp Biol Med (Maywood) (2002) 1.70
Characterization of a phenotypically distinct subpopulation of Leu-2+ cells that suppresses T cell proliferative responses. J Immunol (1983) 1.65
The mechanisms of action of nonsteroidal antiinflammatory drugs. Arthritis Rheum (1989) 1.63
Muscle-derived stem cells. Gene Ther (2002) 1.60
The COX-2 pathway is essential during early stages of skeletal muscle regeneration. Am J Physiol Cell Physiol (2004) 1.58
Growth factors improve muscle healing in vivo. J Bone Joint Surg Br (2000) 1.57
Pathogenesis of fibrosis: role of TGF-beta and CTGF. Curr Opin Rheumatol (2002) 1.57
Acute phase response in exercise. III. Neutrophil and IL-1 beta accumulation in skeletal muscle. Am J Physiol (1993) 1.54
Antigen markers of macrophage differentiation in murine tissues. Curr Top Microbiol Immunol (1992) 1.47
The use of an antifibrosis agent to improve muscle recovery after laceration. Am J Sports Med (2001) 1.46
Blood borne macrophages are essential for the triggering of muscle regeneration following muscle transplant. Neuromuscul Disord (1999) 1.45
Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential. Nat Cell Biol (2003) 1.38
Chemotactic factor-induced generation of superoxide radicals by human neutrophils: effect of metabolic inhibitors and antiinflammatory drugs. Arthritis Rheum (1979) 1.37
Reduction of myocardial infarct size by neutrophil depletion: effect of duration of occlusion. Am Heart J (1986) 1.31
Macrophages enhance muscle satellite cell proliferation and delay their differentiation. Muscle Nerve (1999) 1.25
ED2+ macrophages increase selectively myoblast proliferation in muscle cultures. Biochem Biophys Res Commun (1997) 1.22
Transforming growth factor-beta regulation of bone morphogenetic protein-1/procollagen C-proteinase and related proteins in fibrogenic cells and keratinocytes. J Biol Chem (1997) 1.21
In vitro and in vivo expression of alpha 7 integrin and desmin define the primary and secondary myogenic lineages. Dev Biol (1993) 1.19
BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice. Mol Ther (2002) 1.19
The use of flow cytometry to measure neutrophil function. J Immunol Methods (1999) 1.17
Leukocyte depletion attenuates vascular injury in postischemic skeletal muscle. Am J Physiol (1988) 1.14
Effects of non-steroidal anti-inflammatory agents on human neutrophil functions in vitro and in vivo. Biochem Pharmacol (1984) 1.08
Role of cyclooxygenase-1 and -2 in satellite cell proliferation, differentiation, and fusion. Muscle Nerve (2004) 1.08
Muscle derived, cell based ex vivo gene therapy for treatment of full thickness articular cartilage defects. J Rheumatol (2002) 1.07
Angiotensin II, TGF-beta and renal fibrosis. Contrib Nephrol (2001) 1.06
Healing of experimental muscle strains and the effects of nonsteroidal antiinflammatory medication. Am J Sports Med (1986) 1.03
Immunocytochemical demonstration of myosin heavy chain expression in human muscle. J Neurol Sci (1989) 0.97
Macrophages regulate proliferation and differentiation of satellite cells. Biochem Biophys Res Commun (1994) 0.97
Mechanisms of NSAID-induced hepatotoxicity: focus on nimesulide. Drug Saf (2002) 0.94
Post-injection fibrosis of skeletal muscle: a clinical problem. A personal series of 169 cases. Int Orthop (1980) 0.94
Effect of COX-2 inhibitor NS-398 on expression of PGE2 receptor subtypes in M-1 mouse CCD cells. Am J Physiol Renal Physiol (2001) 0.92
Free radical defense mechanisms and neutrophil infiltration in postischemic skeletal muscle. Am J Physiol (1989) 0.92
Interactions between muscle and the immune system during modified musculoskeletal loading. Clin Orthop Relat Res (2002) 0.90
Nonsteroidal antiinflammatory agents inhibit stimulated neutrophil adhesion to endothelium: adenosine dependent and independent mechanisms. Inflammation (1994) 0.89
Administration of the non-steroidal anti-inflammatory drug ibuprofen increases macrophage concentrations but reduces necrosis during modified muscle use. Inflamm Res (2003) 0.87
Biomechanical and histologic assessment of a controlled muscle strain injury treated with piroxicam. Am J Sports Med (1994) 0.86
Myosin isoform transitions and physiological properties of regenerated and re-innervated soleus muscles of the rat. Neuromuscul Disord (1991) 0.81
NS-398, a selective cyclooxygenase-2 blocker, acutely inhibits receptor-mediated contractions of rat aorta: role of endothelium. Eur J Pharmacol (2003) 0.79
NSAID association with gastrointestinal bleeding and peptic ulcer. Agents Actions Suppl (1991) 0.78
Adverse cardiovascular effects of NSAIDs in patients with congestive heart failure. Drug Saf (1997) 0.77
Myosin heavy chain expression in human muscle cocultured with mouse spinal cord. J Neurol Sci (1989) 0.77
Synergy among agents inhibiting granulocyte aggregation. Inflammation (1982) 0.76
A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell (2008) 18.18
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol (2002) 17.41
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature (2009) 12.58
Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab (2007) 9.62
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev (2003) 9.58
An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell (2010) 6.76
An Arabidopsis thaliana T-DNA mutagenized population (GABI-Kat) for flanking sequence tag-based reverse genetics. Plant Mol Biol (2003) 6.57
Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol (2002) 4.61
Identification of ligands for DAF-12 that govern dauer formation and reproduction in C. elegans. Cell (2006) 3.82
Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther (2007) 3.69
MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res (2010) 3.57
Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer. Cancer Cell (2011) 3.53
Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions. Hum Gene Ther (2005) 3.49
A plaque-specific antibody clears existing β-amyloid plaques in Alzheimer's disease mice. Neuron (2012) 3.32
A futile metabolic cycle activated in adipocytes by antidiabetic agents. Nat Med (2002) 3.22
Therapeutic targeting of SPINK1-positive prostate cancer. Sci Transl Med (2011) 2.83
Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol (2004) 2.78
Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest (2002) 2.59
Signaling by target of rapamycin proteins in cell growth control. Microbiol Mol Biol Rev (2005) 2.56
MicroRNAs in NF-kappaB signaling. J Mol Cell Biol (2011) 2.50
miR-301a as an NF-κB activator in pancreatic cancer cells. EMBO J (2010) 2.47
Orbital cerebrospinal fluid space in glaucoma: the Beijing intracranial and intraocular pressure (iCOP) study. Ophthalmology (2012) 2.44
Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res (2009) 2.43
Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat Biotechnol (2007) 2.41
Muscle injuries and repair: current trends in research. J Bone Joint Surg Am (2002) 2.31
Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma. Nat Commun (2013) 2.27
Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique. Nat Protoc (2008) 2.26
A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts. J Am Coll Cardiol (2007) 2.26
Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions. Bone (2005) 2.26
Low-temperature oxidation of CO catalysed by Co(3)O(4) nanorods. Nature (2009) 2.24
Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis. EMBO J (2009) 2.21
Extracellular heat shock protein-90alpha: linking hypoxia to skin cell motility and wound healing. EMBO J (2007) 2.20
IOC consensus paper on the use of platelet-rich plasma in sports medicine. Br J Sports Med (2010) 2.15
Roles played by chemolipiodolization and embolization in chemoembolization for hepatocellular carcinoma: single-blind, randomized trial. J Natl Cancer Inst (2012) 2.10
Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. Arthritis Rheum (2006) 2.08
Characterization of KRAS rearrangements in metastatic prostate cancer. Cancer Discov (2011) 2.02
A role for cell sex in stem cell-mediated skeletal muscle regeneration: female cells have higher muscle regeneration efficiency. J Cell Biol (2007) 2.01
Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor RORgamma. Mol Endocrinol (2010) 1.98
VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res (2005) 1.96
Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis. J Biol Chem (2007) 1.96
NF-κB inhibition delays DNA damage-induced senescence and aging in mice. J Clin Invest (2012) 1.91
Transforming growth factor alpha (TGFalpha)-stimulated secretion of HSP90alpha: using the receptor LRP-1/CD91 to promote human skin cell migration against a TGFbeta-rich environment during wound healing. Mol Cell Biol (2008) 1.88
Coordinated regulation of polycomb group complexes through microRNAs in cancer. Cancer Cell (2011) 1.86
Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium. J Am Coll Cardiol (2008) 1.85
TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase. J Biol Chem (2006) 1.85
Angiotensin II receptor blockade administered after injury improves muscle regeneration and decreases fibrosis in normal skeletal muscle. Am J Sports Med (2008) 1.83
A novel miR-155/miR-143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells. EMBO J (2012) 1.82
A new species of yunnanozoan with implications for deuterostome evolution. Science (2003) 1.82
Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and binding valence on viral neutralization. J Mol Biol (2005) 1.80
Novel role for Netrins in regulating epithelial behavior during lung branching morphogenesis. Curr Biol (2004) 1.80
Ethanol exposure induces differential microRNA and target gene expression and teratogenic effects which can be suppressed by folic acid supplementation. Hum Reprod (2008) 1.79
Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development. Curr Med Chem (2008) 1.78
Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis. Cancer Res (2008) 1.76
Apoptosis and the target genes of microRNA-21. Chin J Cancer (2011) 1.74
Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol (2002) 1.74
Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression. Cancer Res (2009) 1.74
Intralesional targeted alpha therapy for metastatic melanoma. Cancer Biol Ther (2005) 1.71
Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation. Cancer Cell (2010) 1.71
T-DNA-mediated transfer of Agrobacterium tumefaciens chromosomal DNA into plants. Nat Biotechnol (2008) 1.68
Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis. Proc Natl Acad Sci U S A (2011) 1.64
Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells. Blood (2014) 1.64
Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. Am J Physiol Gastrointest Liver Physiol (2009) 1.63
Human neuropathy target esterase catalyzes hydrolysis of membrane lipids. J Biol Chem (2002) 1.62
Amphiregulin carboxy-terminal domain is required for autocrine keratinocyte growth. J Invest Dermatol (2010) 1.62
Transcriptional profiling implicates novel interactions between abiotic stress and hormonal responses in Thellungiella, a close relative of Arabidopsis. Plant Physiol (2006) 1.62
Improvement of muscle healing through enhancement of muscle regeneration and prevention of fibrosis. Muscle Nerve (2003) 1.61
The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization. Mol Cell (2004) 1.61
Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol Ther (2005) 1.59
Characterization of genetically modified T-cell receptors that recognize the CEA:691-699 peptide in the context of HLA-A2.1 on human colorectal cancer cells. Clin Cancer Res (2009) 1.59
Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions. J Biol Chem (2010) 1.57
[Changes of China agricultural climate resources under the background of climate change. VIII. Change characteristics of heat resources during the growth period of double cropping rice in Jiangxi Province]. Ying Yong Sheng Tai Xue Bao (2011) 1.56
Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice. Hum Gene Ther (2002) 1.56
Virion-wide protein interactions of Kaposi's sarcoma-associated herpesvirus. J Virol (2008) 1.54
Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma. Ann Thorac Surg (2012) 1.54
Mfge8 is critical for mammary gland remodeling during involution. Mol Biol Cell (2005) 1.53
Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin. J Biol Chem (2004) 1.53
Generation of NY-ESO-1-specific CD4+ and CD8+ T cells by a single peptide with dual MHC class I and class II specificities: a new strategy for vaccine design. Cancer Res (2002) 1.52
Perivascular multi-lineage progenitor cells in human organs: regenerative units, cytokine sources or both? Cytokine Growth Factor Rev (2009) 1.51
90Y-edotreotide for metastatic carcinoid refractory to octreotide. J Clin Oncol (2010) 1.49
Inverse relationship between long-chain n-3 fatty acids and risk of sudden cardiac death in patients starting hemodialysis. Kidney Int (2013) 1.48
Development of a tissue-engineered vascular graft combining a biodegradable scaffold, muscle-derived stem cells and a rotational vacuum seeding technique. Biomaterials (2007) 1.48
Revealing a natural marine product as a novel agonist for retinoic acid receptors with a unique binding mode and inhibitory effects on cancer cells. Biochem J (2012) 1.44
Human and mouse enamel phenotypes resulting from mutation or altered expression of AMEL, ENAM, MMP20 and KLK4. Cells Tissues Organs (2008) 1.43
Monoclonal antibody clearance. Impact of modulating the interaction of IgG with the neonatal Fc receptor. J Biol Chem (2006) 1.42
Purification and culture of human blood vessel-associated progenitor cells. Curr Protoc Stem Cell Biol (2008) 1.42
Acute kidney injury in a Chinese hospitalized population. Blood Purif (2010) 1.41
Calcium/calmodulin-dependent protein kinase (CaMK) IV mediates nucleocytoplasmic shuttling and release of HMGB1 during lipopolysaccharide stimulation of macrophages. J Immunol (2008) 1.39
Human pericytes for ischemic heart repair. Stem Cells (2013) 1.39